Evidence map›Paper›PMID 31933581›Full record

ReviewBreast care (Basel, Switzerland)2019

European Guidelines on the Organisation of Breast Centres and Voluntary Certification Processes.

Laura Biganzoli, Lorenza Marotti, Maria-Joao Cardoso, Luigi Cataliotti, Giuseppe Curigliano, Jack Cuzick, Aaron Goldhirsch, Marjut Leidenius, Robert Mansel, Christos Markopoulos and 2 more

Abstract readReview
In one paragraph

Review in Breast care (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Baseline and earlyCancer imaging : the official publication of the International Cancer Imaging Society · 2024
    Article
  4. Article
  5. Review
  6. Modern surgical treatment of breast cancer.Annals of medicine and surgery (2012) · 2020
    Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Laura BiganzoliBreast Unit, Nuovo Ospedale di Prato, Prato, Italy.
Lorenza MarottiEUSOMA, Florence, Italy.
Maria-Joao CardosoBreast Unit, Champalimaud Clinical Center/Champalimaud Foundation, Nova Medical School, Lisbon, Portugal.
Luigi CataliottiBCCERT and SENONETWORK Italia, Florence, Italy.
Giuseppe CuriglianoDepartment of Oncology and Haematology, University of Milan, Milan, Italy.
Jack CuzickWolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom.
Aaron GoldhirschInternational Breast Cancer Study Group, Bern, Switzerland.
Marjut LeideniusBreast Surgery Unit, Comprehensive Cancer Center, Helsinki University Hospital, Helsinki, Finland.
Robert ManselCardiff University School of Medicine, Cardiff, United Kingdom.
Christos MarkopoulosMedical School, National and Kapodistrian University of Athens, Athens, Greece.
Lynda WyldDepartment of Oncology and Metabolism, University of Sheffield, Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust, Doncaster, United Kingdom.
Isabel T RubioBreast Surgical Oncology Unit, Clinica Universidad de Navarra, Madrid, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundEUSOMA undertook the commitment of defining the requirements for a specialist breast centre, which has become the reference document for the implementation of breast centres. SUMMARY: The EUSOMA requirements for a specialist breast centre give clear indications regarding the requisite caseload, dedicated team composition (core and non-core team), organisation, availability of services and equipment throughout the patient pathway, quality control, and application of a multidisciplinary approach. The minimum number of cases is 150 newly diagnosed breast cancer cases per year. Based on the EUSOMA requirements, a voluntary and accredited certification scheme has been developed. In Europe, other voluntary certification schemes are available, such as those developed by the German Cancer Society and German Society for Breast Disease, the National Cancer Peer Review Programme in the UK, and the "label de qualité" established by the Swiss Anticancer League and the Swiss Senology Society. The European Commission Initiative on Breast Cancer (ECIBC) has overseen the development of a European Quality Assurance Scheme. KEY MESSAGES: Nearly 20 years after the initial publication of the EUSOMA requirements, ensuring that all breast cancer patients in Europe are treated only in certified breast centres should be considered a high priority and eventually achieved through collaborative efforts.

Indexed as

Breast centreCertificationMultidisciplinaryQuality controlQuality indicators

Identifiers

PMID31933581
PMCPMC6940462

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.